MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) — Syneos Health, Inc. SYNH (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced that the Company’s stockholders approved an agreement to take the Company private through an acquisition by a consortium of private investment firm affiliates comprised…Read More
Syneos Health Stockholders Approve Agreement with Private Investment Consortium Syneos Health NASDAQSYNH
